InBody continues to work closely with academic researchers on a global scale to develop more in-depth clinical applications of body composition. With our long history in the industry, we provide more than 7,000 research publications. Research title with ★ indicates InBody recommended paper.
Clinical implications with tolvaptan on monitored bioimpedance-defined fluid status in patients with cirrhotic ascites: an obse
Hepatology | SMI, TBW, ICW, ECW, ECW/TBW | Shiba et al. | 2020 | Japan | BMC Gastroentorology
Prognostic value or clinical implications of fluid status monitoring in liver cirrhosis are not fully elucidated. Tolvaptan, an orally available, selective vasopressin V2-receptor antagonist approved for hyponatremia in the United States and European Union. It is also used for cirrhotic ascites at a relatively low dose (3.75 mg to 7.5 mg) in Japan, exerts its diuretic function by excreting electrolyte-free water. We hypothesized that bioimpedance-defined dynamic changes in fluid status allow prediction of response of V2 antagonism and survival …
Estimation of standard liver volume using CT volume, body composition, and abdominal geometry measurements
Hepatology | SMM, BFM, PBF | Xiaopeng Yang, et al. | 2018 | Korea | Yonsei Medical Journal
Purpose The present study developed formulas for estimation of standard liver volume (SLV) with high accuracy for the Korean population. Materials and Methods SLV estimation formulas were established using gender-balanced and gender-unbalanced measurements of anthropometric variables, body composition variables, and abdominal geometry of healthy Koreans (n= 790). Total liver volume excluding blood volume, was measured based on CT volumetry. Results SLV estimation formulas as preferred in various conditions of data …
Clinical usefulness of non‐protein respiratory quotient measurement in non‐alcoholic fatty liver disease
Hepatology | PBF | Keiko Korenaga et al. | 2013 | Japan | Hepatology Research
Aim Little is known about the effects of non‐alcoholic fatty liver disease (NAFLD) on energy metabolism, although this disease is associated with metabolic syndrome. We measured non‐protein respiratory quotient (np RQ) using indirect calorimetry, which reflects glucose oxidation, and compared this value with histological disease severity in NAFLD patients. Methods Subjects were 32 patients who were diagnosed with NAFLD histopathologically. Subjects underwent body composition analysis and indirect calorimetry, and np RQ was …
Therapeutic effect of hybrid training of voluntary and electrical muscle contractions in middle-aged obese women with nonalcoho
Hepatology | BW, SMM, BFM | Sechang Oh et al. | 2015 | Korea | Journal of Therapeutics and Clinical Risk Management
Background Exercise training is an effective therapy for nonalcoholic fatty liver disease (NAFLD). Hybrid training (HYB) of voluntary and electrical muscle contractions was developed to prevent disuse atrophy during space flight. HYB can be applied to obtain a strength training effect accompanying articular movement. In this pilot study, we aimed to investigate the therapeutic efficacy of HYB in NAFLD. Methods A total of 15 middle-aged obese women with NAFLD who had no improvement in serum alanine aminotransferase …
Effects of nucleos (t) ide analogs on body composition in HBV-infected men: An age-and BMI-matched, cross-sectional study
Hepatology | BFM, VFA, WHR | Yao J et al. | 2016 | China | Nutrition
Abstract Objective Chronic hepatitis B (CHB) requires long-term treatment with nucleos (t) ide analogs (NAs). The goal of the present study was to evaluate the effects of long-term treatment with NAs on body composition in men with CHB. Method We performed a cross …
Body cell mass is a useful parameter for assessing malnutrition and severity of disease in non-ascitic cirrhotic patients with
Hepatology | TBW, BCM | TAKUMI KAWAGUCHI | 2008 | Japan | International Journal of Molecular Medicine
Body cell mass (BCM) is a nutritional parameter, however, changes in BCM in patients with non-ascitic liver cirrhosis (LC) in comparison to patients with other malnutritional diseases remains unclear. We investigated the difference in BCM between patients with LC and malnourished gastrointestinal disease controls (M. CON), and examined the relationship between BCM and the severity of LC. Results demonstrated that serum nutritional parameters were not significantly different between the LC (n= 56) and M. CON groups (n …
Whole‐body vibration for patients with nonalcoholic fatty liver disease: a 6‐month prospective study
Hepatology | BW, SMM, BFM, VFA | S. Oh et al. | 2019 | Japan | Physiological Reports
Physical exercise has demonstrated benefits for managing nonalcoholic fatty liver disease (NAFLD). However, in daily life maintaining exercise without help may be difficult. A whole‐body vibration device (WBV) has been recently introduced as an exercise modality that may be suitable for patients who have difficulty engaging in exercise. We tested WBV in patients with NAFLD and estimated its effectiveness. We studied the effects of a 6‐month WBV program on hepatic steatosis and its underlying pathophysiology in 25 patients with NAFLD …
Predictors associated with increase in skeletal muscle mass after sustained virological response in chronic hepatitis C treated
Hepatology | SMI | K Yoh et al. | 2017 | Japan | Nutrients
Aims: We aimed to examine changes in skeletal muscle mass in chronic hepatitis C (CHC) patients undergoing interferon (IFN)-free direct acting antivirals (DAAs) therapy who achieved sustained virological response (SVR). Patients and methods: A total of 69 CHC patients treated with DAAs were analyzed. We compared the changes in skeletal muscle index (SMI) using bio-impedance analysis at baseline and SMI at SVR. SMI was calculated as the sum of skeletal muscle mass in upper and lower extremities divided by height …